Type 1 Diabetes Manifested Solely by 2-h Oral Glucose Tolerance Test Criteria

  1. Carla J. Greenbaum,
  2. David Cuthbertson,
  3. Jeffrey P. Krischer and
  4. the Diabetes Prevention Trial of Type 1 Diabetes Study Group
  1. From the Department of Veterans Affairs (C.J.G.), Puget Sound Health Care System and the Department of Medicine (C.J.G.), University of Washington, Seattle, Washington; and the H. Lee Moffitt Cancer Center and Research Institute (D.C., J.P.K.), University of South Florida, Tampa, Florida.
  1. Address correspondence and reprint requests to Carla Greenbaum MD, Diabetes Clinical Research Unit, Clinical Research Center, Virginia Mason Research Center, 1201 9th Ave., Seattle, WA 98101. E-mail: cjgreen{at}vmresearch.org .

Abstract

The clinical presentation of type 1 diabetes usually involves symptoms such as polyuria and polydipsia. However, investigators in the Diabetes Prevention Trial of Type 1 Diabetes (DPT-1) have detected a group of subjects with type 1 diabetes who have a different phenotype. These subjects are asymptomatic, have normal (<6.1 mmol/l) (group A) or impaired (6.1- <7.0 mmol/l) (group B) fasting glucose, but have 2-h glucose values >11.1 mmol/l on their oral glucose tolerance tests (OGTT). Of the 585 OGTTs performed on islet cell antibody (ICA)-positive relatives with insulin autoantibodies (IAA) or low first-phase insulin response (FPIR), normal glucose tolerance (NGT) was found in 427 subjects; impaired glucose tolerance (IGT) was found in 87 subjects, and diabetes was found by 2-h OGTT criteria alone in 61 subjects. Despite marked differences in 2-h glucose values (NGT 5.8 ± 1.1 mmol/l, IGT 8.9 ± 0.9 mmol/l, and group A 13.5 ± 2.5 mmol/l), there were no significant differences in fasting glucose values among NGT (4.8 ± 0.5 mmol/l), IGT (5.03 ± 0.5 mmol/l), and group A (4.99 ± 0.7 mmol/l) categories. Mean FPIR was higher in subjects with NGT compared with subjects with IGT and subjects diagnosed by 2-h OGTT criteria alone. However, the correlation between FPIR and 2-h glucose value was low (r2 = 0.14). Multivariate analysis demonstrated that additional independent variables provide smaller contributions to the 2-h glucose value. In conclusion, there are asymptomatic type 1 diabetic subjects whose diabetes was diagnosed by the 2-h criteria on OGTT alone. Despite the importance of β-cell dysfunction in the pathogenesis of type 1 diabetes, factors other than impaired FPIR must also contribute to postprandial glucose tolerance in these subjects.

Footnotes

  • AUC, area under the curve; DPT-1, Diabetes Prevention Trial of Type 1 Diabletes; FPIR, first-phase insulin response; HOMA-β, homeostasis model assessment of β-cell function; HOMA-IR, homeostasis model assessment of insulin resistance; IAA, insulin autoantibody; ICA, islet cell antibody; IDS, Immunology of Diabetes Society; IGT, impaired glucose tolerance; IVGTT, intravenous glucose tolerance test; JDF U, Juvenile Diabetes Foundation units; NDDG, National Diabetes Data Group; NGT, normal glucose tolerance; NIH, National Institutes of Health; OGTT, oral glucose tolerance test.

    • Accepted October 16, 2000.
    • Received August 18, 1999.
« Previous | Next Article »Table of Contents